Google Preview Button

ANTITHROMBOTIC DRUG THERAPY IN CARDIOVASCULAR DISEASE

Askari, A.

ISBN-139781603272346
PublicadoMarzo 2010
Edición
IdiomaInglés
Páginas450
Peso1.800 gramos
Dimensiones20 x 27 x 3 cms.
EditorialHUMANA PRESS
Disponibilidad2-3 Semanas
PVP sin IVA199,95 €

Gastos de envío GRATIS en España y Portugal
para pedidos que, sin incluir IVA, superen 100€.

Puede encontrar libros similares en:

Libros | Medicina | Circulatorio (Sistema)

Libros | Medicina | Cirugía | Vascular

About this book

A thrombus, also called a blood clot, is an aggregation of platelets, fibrin, clotting factors, and the cellular elements of the blood attached to the interior wall of a vein or artery, sometimes occluding the lumen of the vessel. This book describes the mechanisms involved and how the various drugs work that have been developed to prevent and treat thrombi.

Written for: Cardiologists, interventional cardiologists and radiologists, vascular surgeons, and internists

Keywords:

  • Antiplatelet therapies
  • Antithrombotic therapies
  • Atrial fibrillation
  • Deep vein thrombosis
  • Myocardial infarction
  • Pulmonary embolism
  • Thrombosis
  • Unstable angina

Table of contents

Part I: Basic Principles

  • The Link Between Inflammation and Thrombosis - James de Lemos
  • The Platelet in Arterial and Venous Thrombosis - Edward F. Plow
  • The Coagulation Cascade in Arterial and Venous Thrombosis - Kandice Marchant
  • Genetics of Thrombosis - Marc S. Penn

Part II: Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease

  • Aspirin for Primary and Secondary Prevention - Mike Lauer
  • Clopidogrel and Thienopyridines in Stable CAD Patients - Marcus Flather

Part III: Antithrombotic Therapy for NSTE ACS

  • Anti-platelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors - Deepak Bhatt
  • Unfractionated Heparin and Enoxaparin:. - Elliott M. Antman
  • The Direct Thrombin Inhibitors - A. Michael Lincoff
  • Synthetic Factor Xa Inhibition, Fondaparinux - Shamir Mehta

Part IV: Antithrombotic Therapy for STEMI

  • Antiplatelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors - Mark Sabatine
  • Antithrombin Therapies: Unfractionated Heparin, Enoxaparin, Fondaparinux - Arman T. Askari
  • Fibrinolysis and Facilitated PCI - Sorin J. Brener

Part V: Antithrombotic Therapy in Interventional Cardiology

  • Antithrombotic Therapy in Percutaneous Coronary Intervention - Adrian W. Messerli
  • Antithrombotic Therapy in Carotid and Peripheral Intervention - Samir Kapadia
  • Monitoring of Antithrombotic Therapies - Steve Steinhubl

Part VI: Antithrombotic Therapy in Venous Thromboembolic Disease

  • Antithrombotic Therapy for DVT/PE - John R. Bartholemew
  • Fibrinolysis for PE - Heather Gornik
  • Duration of Anticoagulation Following VTE - Samuel Goldhaber

Part VII: Clinical Considerations

  • Antithrombotic Therapy for Atrial Fibrillation - Allan Klein
  • Antithrombotic Therapy for Valvular Heart Disease- Brian Hoyt
  • Antithrombotic Therapy for Cardiomyopathy - Wilson Tang
  • Heparin-Induced Thrombocytopenia - Arman T. Askari
  • "Resistance" to Antiplatelet Therapies - Peter Berger
  • Cerrar vista previa